Humidified High Flow Nasal Cannula Versus Nasal Intermittent Positive Ventilation in Neonates
Respiratory Insufficiency
About this trial
This is an interventional treatment trial for Respiratory Insufficiency focused on measuring NIPPV, HHFNC, RDS, neonate
Eligibility Criteria
Inclusion Criteria:
- Birth weight > 1000 grams and > 28 weeks gestation
- have respiratory distress syndrome and need assistant ventilation
Exclusion Criteria:
- Birth weight < 1000 grams
- Estimated gestation < 28 weeks
- infants have contraindications for use of non-invasive ventilation
- Active air leak syndrome
- Infants with abnormalities of the upper and lower airways; such as Pierre- Robin, Treacher-Collins, Goldenhar, choanal atresia or stenosis, cleft lip and/or palate, or
- Infants with significant abdominal or respiratory malformations including trachea-esophageal fistula, intestinal atresia, omphalocele, gastroschisis, and congenital diaphragmatic hernia.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
HHFNC
NIPPV
HHFNC is provided nasal cannula. Ventilator settings:fraction of inspired oxygen (FiO2):21-40%,flow:2-8(litre,L)/min,to maintain arterial blood hemoglobin oxygen saturation ( SaO2) at 90-95% The weaning process is left to the discretion of the attending physician.,when FiO2: 25%,flow:2(litre,L)/min.
NIPPV is provided via binasal prongs. Ventilator settings:FiO2:21-40%,peak inspiratory pressure( PIP):12-22cm H2O,positive and expiratory pressure(PEEP):5-7cm H2O,Rate:30-60 per minute to maintain SaO2 at 90-95%,The weaning process is left to the discretion of the attending physician,when FiO2: 25%,mean airway pressure (MAP):6cm H2O,R:30 per minute .